Trillium Health Care Products has been sold to New Water Capital

Lincoln International (“Lincoln”), a leading global mid-market investment bank, is pleased to announce that Richardson Capital (“Richardson”) has sold Trillium Health Care Products (“Trillium” or the “Company”) to an affiliate of New Water Capital L.P. Terms of the transaction were not disclosed.

Trillium, headquartered in Brockville, Ontario, is a leading provider of outsourced manufacturing and packaging solutions to the world’s largest pharmaceutical and over-the-counter personal care product companies. Trillium has built a reputation in the pharmaceutical industry for its focus on quality and technical expertise in short and medium production runs across three dosage forms: liquid, solid and semi-solid. Trillium’s product capabilities include syrups, solutions, suspensions, tablets, capsules, ointments, lotions and other related OTC and Rx products primarily serving cough and cold applications. All of the products that Trillium manufactures are subject to both Health Canada and FDA regulation — therefore, the Company’s long-term track record of quality assurance, compliance and testing throughout the entire supply chain process is critical to customers’ reputations and builds a significant barrier to entry.

Lincoln acted as the exclusive investment banking representative for Richardson and Trillium, working closely with the Company’s management team and shareholders throughout the sale process. This included providing advisory expertise and managing the preparatory, marketing, negotiation and due diligence phases of the transaction.

Richardson has sold Capital Trillium to New Water
  • 2018
    Close Year
  • Healthcare | Packaging
    Industry
  • Private Equity
    Client Type
  • Financial | Cross-border
    Transaction Type
  • Canada | USA
    Countries

Meet our Senior Team